Diffuse Lung Disease
-
Low-nicotine cigarettes unlikely to trigger sustained compensatory smoking, meta-analysis finds
Hasmeena Kathuria, MD, said the findings provide further support that very low nicotine content cigarettes do not lead to substantially increased smoking or carbon monoxide exposure.
-
Air pollution and dysglycemia: Implications for pulmonary practice
Air pollution exposure is linked to incident diabetes and adverse glycemic biomarkers. Clinicians can help patients assess their exposure and provide practical counseling.
-
When PH and ILD meet: From overlap to a unified disease paradigm
For clinicians, the shift in the PH-ILD space demands a broader perspective that integrates vascular and parenchymal disease, emphasizes early detection, and prioritizes multidisciplinary care.
-
The changing landscape of lung transplant allocation
The composite allocation score has transformed clinical practice, bringing several improvements but also limitations and opportunities for further refinement.
-
Varenicline sampling with minimal guidance may boost smoking cessation rates
According to the investigators, the medication sampling model may lower barriers to engagement and allow patients to consider cessation on their own terms.
-
TETON-1 treatment effects offer hope for patients with idiopathic pulmonary fibrosis
Christopher King, MD, FCCP, and Steven D. Nathan, MD, FCCP, discuss the clinical implications of inhaled treprostinil, including the medication’s potential use in future combination treatment strategies.
-
Positive results from TETON-1 trial introduce potential new therapy for IPF
Positive results from the TETON trials and expanding treatment options are encouraging for pulmonologists who are used to working with a limited toolkit for slowing disease progression in their patients with IPF.
-
Honoring a legacy, empowering the future
The John R. Addrizzo, MD, FCCP, Endowed Research Grant in Sarcoidosis, a transformative and permanent fund dedicated to advancing research in sarcoidosis, is not only a tribute to a beloved husband, father, grandfather, and physician but also a beacon for progress and discovery.
-
Pulmonary rehabilitation in ILD and PH: Expanding access beyond the center
Pulmonary rehabilitation remains one of the most effective interventions available for chronic respiratory disease. The research has shown a need for structured long-term maintenance programs for patients with ILD and PH.
-
Psilocybin-assisted therapy bests nicotine patch for smoking cessation in pilot study
At six months following the target quit date, 40.5% of participants in the psilocybin group achieved biochemically verified prolonged abstinence compared with only 10.0% in the nicotine patch group.
-
When oil infrastructure burns: What pulmonary clinicians should know
Recent conflict in the Middle East sheds light on oil fires as respiratory exposure events. Pulmonary clinicians need to be prepared to treat both acute and chronic symptoms from these exposures.
-
Phase 3 TETON trials demonstrate positive results for inhaled treprostinil for IPF
Steven D. Nathan, MD, FCCP, said the evidence shows the drug is effective for treating pulmonary hypertension and may slow or prevent fibrosis progression.
